In the realm of Greek mythology, a tale unfolds that resonates deeply with the challenges faced by oncologists. The story of Eos, the goddess of dawn, and her mortal lover, Tithonus, serves as a poignant reminder of the delicate balance between life and longevity. Eos, in her love for Tithonus, sought immortality for him, but in a tragic twist, she forgot to ask for eternal youth. The consequences were devastating, as Tithonus lived on, but his body deteriorated, leaving him immortal yet not truly alive.
This myth finds its echo in the modern oncology clinic. Consider the middle-aged woman, cured of breast cancer, who now struggles with weakened bones and joint pain, making even climbing stairs a challenge. Or the young lymphoma patient whose heart, affected by treatment, ages faster than the rest of his body. These patients, though free of disease, face a new set of struggles, highlighting the importance of not just extending life but ensuring its quality.
Here's where it gets controversial: modern oncology has made remarkable strides, offering patients years, even decades, of additional time. But the question arises: is this time truly livable? This is where the longevity movement, championed by authors like Peter Attia, David Sinclair, and Eric Topol, intersects with oncology in ways that are both intriguing and relevant.
Attia, despite recent criticism, has become a prominent voice in the field. His book, "Outlive," takes a clinical approach, emphasizing the prevention of atherosclerosis, cancer, neurodegeneration, and metabolic diseases. As an oncologist, I resonate with his perspective, knowing that by the time disease manifests, it may be too late.
Sinclair's "Lifespan" delves into the molecular possibilities, arguing that aging is driven by epigenetic information loss. This aligns surprisingly well with the cellular dysfunctions we encounter daily in cancer biology. His suggestions, though mostly preclinical, hint at a future where the pathways of aging and oncogenesis may be intertwined.
Topol's "Super Agers" brings the discussion back to the fundamentals. Most people who reach advanced ages with good health do so not because of magic genes or supplements, but because of regular movement, sleep, and a healthy, consistent diet. They maintain social connections and live in less stressful environments. Early detection, not just as a slogan, but as a practice, is key.
For oncology, where early intervention is crucial and survivorship extends long enough for aging to become a comorbidity, this convergence is significant. Cancer remains a central player in the aging story, determining not just lifespan but healthspan. While treatments have improved, the long-term consequences threaten the very longevity patients seek.
Attia's focus on muscular strength and cardiorespiratory fitness addresses our survivorship challenges directly. Sinclair's work on senescence aligns with new therapeutic directions in oncology. Topol's emphasis on social connection resonates with our observations of patients aging differently post-cancer.
Oncology has always navigated the fine line between added time and added burden. The global cancer incidence is rising, especially in low- and middle-income countries where access to infrastructure, screening, and treatment is limited. In places like Brazil, Kenya, and India, the myth of Tithonus takes on a new urgency. It's not just about living long, but about having the means to live at all.
I recall a patient from Southeast Asia, years ago, who survived advanced lung cancer but faced a difficult journey due to treatment toxicity, chronic symptoms, and financial strain. He asked why the time gained had to be so hard. Longevity, to be meaningful, must be equitable. It should not be a privilege of geography or income.
If Eos were to seek guidance today, we would tell her to ask not just for years, but for strength, freedom from frailty and toxicity, and for equity. We would ask for cures, but also for the chance to remain fully oneself, for as long as life allows. Oncology is about giving time, and the longevity movement challenges us to refine this gift. The task is to ensure that the extra time gained is lived with meaning, mobility, and dignity, not merely survived.
